[HTML][HTML] From cell lines to pluripotent stem cells for modelling Parkinson's Disease

E Ferrari, A Cardinale, B Picconi, F Gardoni - Journal of Neuroscience …, 2020 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder
characterized by loss of dopaminergic (DAergic) neurons in the substantia nigra (SN) that …

Pre-Clinical studies identifying molecular pathways of neuroinflammation in Parkinson's disease: a systematic review

M Fathi, K Vakili, S Yaghoobpoor… - Frontiers in Aging …, 2022 - frontiersin.org
Parkinson's disease (PD), the second most common neurodegenerative disorder, is
characterized by neuroinflammation, formation of Lewy bodies, and progressive loss of …

Transcriptome Highlights Cannabinol Modulation of Mitophagy in a Parkinson's Disease In Vitro Model

A Gugliandolo, S Blando, S Salamone, F Pollastro… - Biomolecules, 2023 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of
dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein …

Combining automated organoid workflows with artificial intelligence‐based analyses: opportunities to build a new generation of interdisciplinary high‐throughput …

H Renner, HR Schöler, JM Bruder - Movement Disorders, 2021 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disease and
primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars …

Organs-on-a-Chip

LA Low, M Sutherland, N Lumelsky, S Selimovic… - … -and Microfluidics-Based …, 2020 - Springer
Organs-on-chips, also known as “tissue chips” or microphysiological systems (MPS), are
bioengineered microsystems capable of recreating aspects of human organ physiology and …

Parkinson's disease and the gut: Models of an emerging relationship

AJ Bindas, S Kulkarni, RA Koppes, AN Koppes - Acta biomaterialia, 2021 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disease characterized by a
progressive loss of fine motor function that impacts 1-2 out of 1,000 people. PD occurs …

Dictyostelium discoideum as a Model for Investigating Neurodegenerative Diseases

HN Haver, KM Scaglione - Frontiers in Cellular Neuroscience, 2021 - frontiersin.org
The social amoeba Dictyostelium discoideum is a model organism that is used to investigate
many cellular processes including chemotaxis, cell motility, cell differentiation, and human …

[HTML][HTML] Unraveling brain diseases: the promise of brain-on-a-chip models

L Cerutti, M Brofiga - Journal of Neuroscience Methods, 2024 - Elsevier
Brain disorders, encompassing a wide spectrum of neurological and psychiatric conditions,
present a formidable challenge in modern medicine. Despite decades of research, the …

In vitro and in vivo models for anti-amyloidosis nanomedicines

A Kakinen, I Javed, TP Davis, PC Ke - Nanoscale Horizons, 2021 - pubs.rsc.org
Amyloid diseases are global epidemics characterized by the accumulative deposits of cross-
beta amyloid fibrils and plaques. Despite decades of intensive research, few solutions are …

Quantifying microglial phagocytosis of apoptotic cells in the brain in health and disease

S Beccari, I Diaz‐Aparicio… - Current protocols in …, 2018 - Wiley Online Library
Apoptosis is a ubiquitous process occurring in the brain under both physiological and
pathological conditions. The central nervous system (CNS) requires an active and efficient …